Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07558824 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Efficacy Trial of a Telemedicine-based Virtual Reality Clinic for the Treatment of Phobias
A NA study, sponsored by University of South Florida.
- Not yet
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT07558824: Clinical Trial NA study, sponsored by University of South Florida.
NCT07558824 is a NA study that has not yet begun recruiting, run by University of South Florida. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07558824, a NA study, has not yet begun recruiting, sponsored by University of South Florida.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a telemedicine-based virtual reality clinic (Doxy.me VR) works to treat dog, spider, and snake phobias in adults. The main questions it aims to answer are: Does Doxy.me VR decrease the severity of phobias better than traditional telemedicine-based treatment? Does this work because it feels more realistic than telemedicine alone?
Primary Outcome
The Severity Measure for Specific Phobia (SMSP) is a 10-item self-report questionnaire that assesses the severity of specific phobia symptoms relative to an individual's feared stimulus. Total scores range from 0 to 4 with higher scores indicating higher phobia severity.
Interventions
- BEHAVIORAL Telemedicine-Based Virtual Reality Exposure Therapy
- BEHAVIORAL Telemedicine-Based Exposure Therapy Using Photos and Videos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-04 |
| Est. Completion | 2028-01 |
| Phase | NA |
What is known before NCT07558824 opens enrollment
NCT07558824 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Telemedicine-Based Virtual Reality Exposure Therapy is the first listed.
NCT07558824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07558824 about?
NCT07558824 is a clinical study titled "A Randomized Controlled Efficacy Trial of a Telemedicine-based Virtual Reality Clinic for the Treatment of Phobias". The goal of this clinical trial is to learn if a telemedicine-based virtual reality clinic (Doxy.me VR) works to treat dog, spider, and snake phobias in adults. The main questions it aims to answer are: Does Doxy.me VR decrease the severity of phobias better than traditional telemedicine-based trea...
What is the current status of trial NCT07558824?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2026-04. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07558824?
The interventions under investigation include: Telemedicine-Based Virtual Reality Exposure Therapy (BEHAVIORAL), Telemedicine-Based Exposure Therapy Using Photos and Videos (BEHAVIORAL).
Who is sponsoring clinical trial NCT07558824?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07558824's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia